BLS Pharmaceuticals Limited (ASX:BLS)
Australia · Delayed Price · Currency is AUD 0.9000
-0.0200 (-2.17%)
Aug 11, 2026, 4:10 PM AEST
BLS Pharmaceuticals Market Cap
BLS Pharmaceuticals has a market cap or net worth of 211.58 million as of August 11, 2026. Its market cap has increased by 91.64% in one year.
Market Cap
211.58M
Enterprise Value
209.34M
Revenue
47.95M
Ranking
n/a
PE Ratio
23.18
Stock Price
0.90
ChartMarket Cap Chart
Since April 10, 2012, BLS Pharmaceuticals's market cap has increased from 31.38M to 211.58M, an increase of 574.25%. That is a compound annual growth rate of 14.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 211.58M | 126.37% |
| Dec 31, 2025 | 93.47M | 68.93% |
| Dec 31, 2024 | 55.33M | 164.50% |
| Dec 29, 2023 | 20.92M | 30.94% |
| Dec 29, 2022 | 15.98M | -13.94% |
| Dec 31, 2021 | 18.56M | 141.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 408.52M |
| Racura Oncology | 390.14M |
| Starpharma Holdings | 332.71M |
| Orthocell | 198.75M |
| Nyrada | 182.70M |
| Dimerix | 165.11M |
| Actinogen Medical | 153.63M |
| Island Pharmaceuticals | 133.16M |